-
Product Insights
Chambers Cogeneration Plant
Chambers Cogeneration Plant is a thermal project located in New Jersey, United States. The project is owned by Atlantic Power Corp; Starwood Energy Group Global LLC. The project came online in 1994. Empower your strategies with our Chambers Cogeneration Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Product Insights
OPDE Chambers Solar PV Park
OPDE Chambers Solar PV Park is a solar PV project located in Louisiana, United States. The project is owned and being developed by OPDE Holding SA. The project is expected to come online in 2024. Empower your strategies with our OPDE Chambers Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...
-
Product Insights
Chambers County Solar PV Park
Chambers County Solar PV Park is a solar PV project located in Alabama, United States. The project is owned by Centaurus Renewable Energy LLC and was developed by Swinerton Renewable Energy Inc. The project came online in 2018. Empower your strategies with our Chambers County Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the...
-
Product Insights
NewLikelihood of Approval Analysis for Cardiomyopathy
Overview How likely is it that the drugs in Cardiomyopathy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cardiomyopathy Overview Cardiomyopathy a disease of the heart muscle, where the walls of...
-
Product Insights
NewLikelihood of Approval Analysis for Dilated Cardiomyopathy
Overview How likely is it that the drugs in Dilated Cardiomyopathy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dilated Cardiomyopathy Overview Dilated cardiomyopathy (DCM) is a condition in which the...
-
Track & Monitor
Innovation in automotive: Piston head combustion chambers
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s Piston head combustion chambers segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – IGV-001 in Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IGV-001 in Glioblastoma Multiforme (GBM) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IGV-001 in Glioblastoma Multiforme (GBM) Drug Details: IGV-001 is under development...
-
Sector Analysis
Pacemakers Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Pacemakers Market Report Overview The pacemaker market was valued at $4.61 billion in 2023 and is forecast to grow at a CAGR of more than 3% during 2023 and 2033. A pacemaker is a device designed to regulate the beating of the heart by providing electrical impulses delivered by the electrodes contacting the heart muscle. Pacemakers Market Outlook 2023-2033 ($ Billion) Buy the Full Report for Detailed Insights on the Pacemakers Market Forecast, Download a Free Sample Report The pacemakers...
-
Sector Analysis
Implantable Cardioverter Defibrillators (ICD) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Implantable Cardioverter Defibrillators Market Report Overview The implantable cardioverter defibrillators market size was $2.76 billion in 2023. The market is expected to register a modest CAGR of more than 2% during 2023-2033. An implantable cardioverter defibrillator (ICD) is an electronic device that monitors the heart’s rhythm and delivers electric pulses if it detects an arrhythmia to restore the heart’s natural rhythm. Implantable Cardioverter Defibrillators Market Outlook, 2023-2033 ($ Billion) Buy the Full Report for More Insights into the Implantable Cardioverter...
-
Sector Analysis
Transcatheter Aortic Valve Replacement (TAVR) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Transcatheter Aortic Valve Replacement (TAVR) Market Report Overview The transcatheter aortic valve replacement (TAVR) market was valued at $8.09 billion in 2023. The market is anticipated to grow at a CAGR of more than 8% from 2023 to 2033. Transcatheter Aortic Valve Replacement (TAVR), also known as, Transcatheter Aortic Valve Implantation (TAVI), is a minimally invasive procedure used to treat severe symptomatic aortic valve stenosis. Aortic stenosis is caused by a narrowing of the aortic valve tissue, often due to...